Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Trump previously met with Ubl and chief executives of U.S. drugmakers Pfizer and Eli Lilly at his Mar-a-Lago estate in Florida in December.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...

Eli Lilly 's blockbuster weight loss drugs, and questions about its valuation. Then, Ricky continues his conversation with ...

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

In total, 234 investments creating 13,500 new jobs over the next five years, 59% of which were in regional locations ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

While first-generation glucagon-like peptide-1 receptor agonists have clearly taken the obesity market by storm, generating billions of dollars for Novo Nordisk A/S and Eli Lilly and Co., several ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...